National Healthcare (NHC) | Financial Analysis & Statements
National Healthcare Corporation Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
386.5M
Gross Profit
153.3M
39.66%
Operating Income
33.1M
8.57%
Net Income
25.2M
6.52%
EPS (Diluted)
$1.58
Balance Sheet Metrics
Total Assets
1.5B
Total Liabilities
451.9M
Shareholders Equity
1.1B
Debt to Equity
0.42
Cash Flow Metrics
Operating Cash Flow
17.8M
Free Cash Flow
6.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
National Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.3B | 1.1B | 1.1B | 1.0B |
| Cost of Goods Sold | 921.1M | 810.9M | 712.3M | 686.2M | 666.1M |
| Gross Profit | 596.7M | 487.0M | 429.2M | 388.1M | 344.9M |
| Gross Margin % | 39.3% | 37.5% | 37.6% | 36.1% | 34.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 46.2M | 43.2M | 41.5M | 41.0M | 40.8M |
| Other Operating Expenses | 377.2M | 311.9M | 288.2M | 277.9M | 203.4M |
| Total Operating Expenses | 423.4M | 355.1M | 329.7M | 318.9M | 244.2M |
| Operating Income | 128.4M | 89.9M | 57.5M | 28.7M | 60.0M |
| Operating Margin % | 8.5% | 6.9% | 5.0% | 2.7% | 5.9% |
| Non-Operating Items | |||||
| Interest Income | 9.8M | 10.1M | 8.4M | 5.1M | 4.7M |
| Interest Expense | 6.4M | 4.1M | 324.0K | 563.0K | 845.0K |
| Other Non-Operating Income | 30.6M | 40.5M | 23.2M | -6.1M | 86.2M |
| Pre-tax Income | 162.4M | 136.4M | 88.7M | 27.2M | 150.0M |
| Income Tax | 39.8M | 34.3M | 23.4M | 7.3M | 11.0M |
| Effective Tax Rate % | 24.5% | 25.2% | 26.4% | 26.6% | 7.3% |
| Net Income | 122.6M | 102.1M | 65.3M | 20.0M | 139.1M |
| Net Margin % | 8.1% | 7.9% | 5.7% | 1.9% | 13.8% |
| Key Metrics | |||||
| EBITDA | 183.3M | 142.6M | 109.9M | 74.8M | 110.4M |
| EPS (Basic) | $7.76 | $6.62 | $4.36 | $1.46 | $9.03 |
| EPS (Diluted) | $7.67 | $6.53 | $4.34 | $1.45 | $8.99 |
| Basic Shares Outstanding | 15472185 | 15393782 | 15310142 | 15410222 | 15347129 |
| Diluted Shares Outstanding | 15472185 | 15393782 | 15310142 | 15410222 | 15347129 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
National Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 92.8M | 76.1M | 107.1M | 58.7M | 107.6M |
| Short-term Investments | 163.0M | 140.1M | 116.5M | 123.9M | 148.4M |
| Accounts Receivable | 139.0M | 135.3M | 108.5M | 100.0M | 96.1M |
| Inventory | 7.8M | 9.0M | 7.4M | 7.1M | 8.6M |
| Other Current Assets | 5.8M | 9.1M | 8.9M | 10.2M | 7.4M |
| Total Current Assets | 461.8M | 424.4M | 406.2M | 353.9M | 426.6M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 47.8M | 79.2M | 94.2M | 120.5M | 156.1M |
| Goodwill | 360.8M | 360.8M | 343.6M | 343.6M | 343.6M |
| Intangible Assets | 19.9M | 19.9M | 7.0M | 7.0M | 7.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 113.9M | 118.3M | 125.4M | 117.1M | 122.3M |
| Total Non-Current Assets | 1.1B | 1.1B | 904.6M | 921.5M | 976.8M |
| Total Assets | 1.5B | 1.5B | 1.3B | 1.3B | 1.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 22.8M | 25.5M | 19.2M | 17.0M | 22.5M |
| Short-term Debt | 41.1M | 39.3M | 30.2M | 34.1M | 32.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 26.0M | 21.4M | 23.0M | 17.6M | 20.1M |
| Total Current Liabilities | 253.6M | 234.8M | 214.5M | 197.9M | 263.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 46.0M | 175.4M | 63.2M | 91.9M | 134.4M |
| Deferred Tax Liabilities | 42.7M | 35.6M | 17.2M | 10.9M | 6.9M |
| Other Non-Current Liabilities | 24.2M | 23.0M | 32.8M | 26.2M | 23.6M |
| Total Non-Current Liabilities | 198.3M | 306.5M | 185.8M | 200.0M | 231.7M |
| Total Liabilities | 451.9M | 541.3M | 400.3M | 397.9M | 494.9M |
| Equity | |||||
| Common Stock | 155.0K | 154.0K | 153.0K | 153.0K | 154.0K |
| Retained Earnings | 833.0M | 752.2M | 687.6M | 656.7M | 669.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.1B | 983.2M | 910.5M | 877.5M | 908.5M |
| Key Metrics | |||||
| Total Debt | 87.1M | 214.8M | 93.4M | 125.9M | 166.7M |
| Working Capital | 208.2M | 189.6M | 191.8M | 156.0M | 163.4M |
Balance Sheet Composition
National Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 122.6M | 102.1M | 65.3M | 20.0M | 139.1M |
| Depreciation & Amortization | 44.9M | 42.0M | 42.0M | 40.5M | 40.7M |
| Stock-Based Compensation | 4.4M | 4.2M | 2.8M | 2.6M | 2.6M |
| Working Capital Changes | 19.2M | -33.9M | 4.7M | -27.4M | -55.4M |
| Operating Cash Flow | 197.6M | 132.2M | 120.6M | 41.6M | 25.5M |
| Investing Activities | |||||
| Capital Expenditures | -36.4M | -27.6M | -27.9M | -26.0M | -39.4M |
| Acquisitions | -5.6M | -228.1M | -7.4M | 0 | -29.1M |
| Investment Purchases | -65.2M | -35.1M | -29.5M | -33.8M | -108.2M |
| Investment Sales | 72.9M | 52.0M | 47.4M | 50.0M | 101.9M |
| Investing Cash Flow | -33.9M | -236.7M | -17.6M | -6.0M | -65.9M |
| Financing Activities | |||||
| Share Repurchases | -14.7M | -13.5M | -2.5M | -9.9M | -836.0K |
| Dividends Paid | -38.7M | -37.0M | -35.6M | -34.6M | -32.0M |
| Debt Issuance | 0 | 150.0M | - | - | - |
| Debt Repayment | -97.0M | -13.9M | -5.0M | -4.7M | -4.4M |
| Financing Cash Flow | -136.0M | 100.3M | -42.5M | -47.6M | -35.3M |
| Free Cash Flow | 148.6M | 79.7M | 83.3M | -21.5M | 23.0M |
| Net Change in Cash | 27.8M | -4.1M | 60.5M | -12.0M | -75.7M |
Cash Flow Trend
National Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.79
Forward P/E
424.91
Price to Book
2.66
Price to Sales
1.88
PEG Ratio
0.08
Profitability Ratios
Profit Margin
7.91%
Operating Margin
8.57%
Return on Equity
11.92%
Return on Assets
5.26%
Financial Health
Current Ratio
1.82
Debt to Equity
8.10
Beta
0.59
Per Share Data
EPS (TTM)
$7.68
Book Value per Share
$68.79
Revenue per Share
$98.10
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NHC | 2.7B | 23.79 | 2.66 | 11.92% | 7.91% | 8.10 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pacs | 5.5B | 28.73 | 5.80 | 22.96% | 3.62% | 377.77 |
| Chemed | 5.6B | 20.88 | 5.36 | 25.28% | 10.48% | 14.68 |
| Option Care Health | 4.5B | 22.35 | 3.36 | 15.20% | 3.67% | 96.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.





